Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
Talmadge E. King(University of California, San Francisco), Roland M. du Bois(Imperial College London), Michiel Thomeer(Universitair Ziekenhuis Leuven), Phil Hormel(InterScience (United States)), Dominique Valeyre(Inserm), Lisa Lancaster(Vanderbilt University Medical Center), Paul W. Noble(Cedars-Sinai Medical Center), Ulrich Costabel(Ruhrlandklinik), Steven A. Sahn(Medical University of South Carolina), Javier Szwarcberg(InterScience (United States)), Williamson Z. Bradford(InterScience (United States)), Carlo Albera(University of Turin)
Cited by 530
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2006|1.3k
Sarcoidosis
|The Lancet|2013|1.1k